生物反应器课件 PAT Introduction.ppt_第1页
生物反应器课件 PAT Introduction.ppt_第2页
生物反应器课件 PAT Introduction.ppt_第3页
生物反应器课件 PAT Introduction.ppt_第4页
生物反应器课件 PAT Introduction.ppt_第5页
已阅读5页,还剩17页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

PAT Introduction PAT Process Analytical Technology What is PAT? What is PAT (and what isnt) ? PAT Enabled SCADA Some Key Elements of a PAT in combination with SCADA Spectrometry Metadata & Experimental context Getting more from your data Is PAT? Installing some shiny new equipment ? Connecting a new probe / cell counter to a bioreactor ? Already standard practice in Bioprocess development ? Little business benefit to early bioprocess development ? An important tool for Quality by Design? What is PAT Process analytical technology (PAT) has been defined by the FDA as a mechanism to design, analyze, and control pharmaceutical manufacturing processes through the measurement of Critical Process Parameters (CPP) which affect Critical Quality Attributes (CQA). PAT should address uncontrolled process variation to mitigate risk of uncontrolled product variability PAT Solutions should be an integral part of a Quality by Design (QbD) strategy Long term goals reduce production cycling time prevent rejection of batches enable real time release increase automation improve energy and material use facilitate continuous processing How do we get there? Define process and product quality What causes variance? What is critical? Understand the process How can we control the process to the desired end product quality? On line monitoring (near infrared) How do we get there? Eliminate primary sources of variance 1) Medium composition: from undefined medium (containing protein extracts), to chemically defined medium with balanced C/N ratio 2) Inoculum: reproducible seedlot preparation, freeze at fixed OD, during mid-log growth phase. Define Quality Where should we finish? Experimental design Design space Control space From: D. Low, Amgen BioProduction 2006, Dublin Tools: SCADA Is the technology fit for purpose ? How much data ? How will you store it ? How will you annotate data ? Is the PAT application going to be on-line ? Is software OPC compliant ? If not , have you assessed interfacing costs ? Tools: NIR Full Spectrum Near Infrared Vibrational spectroscopy (800 2500nm) Non-invasive optical sensing NIR has widespread acceptance in pharmaceutical manufacturing Operational & Technical Flexibility Cost Effective, Robust & Scalable Tools: NIR However, Chemometric models are required to extract biomass,metabolite & catabolite data (other methods are also possible) In addition, large datasets make model building difficult Results: Calibration sensor One CHO run (10 days) New Castle Univerity (UK) 1 Spectra every 2 min 5500 Spectra 2000 Abs reading per spectra 10-15 runs for each calibrations Each Bioreactor run Raw Export file 55 Mb Opus files 75 Mb Calibration to full scale NIR probe calibration data collected in multiple small scale vessel run in parallel Better integration of NIR calibration into Development lifecycle Augment calibrations over the development lifecycle Run 1 Run 2 Run 3 Run 4 Run 5 Small scale Benchtop Bioreactors Calibration set Validation set Calibration Model Transferred to Full scale Production bioreactor Temp pH DOT FT-NIR Full Scale Production Bioreactor Time PharmaManufacturing Benchmarking Study Data (2005) Broad survey of 104 Pharma companies. Limited IT support for transition from bench through process dev to commercialisation Unstructured information collection, storage & retrieval results in more time searching for data Limited coordination across groups and sites affects the ability to meet development cycle times (time to human, time to clinic, etc) and product cost targets Lack of information visibility & context limit the effectiveness of portfolio and project management processes 5hr per week on average looking for data Cant find data 25 % of time leading to repeating 8% of experiments and increased R&D costs Limited and inefficient traceability (paper based) Few IT systems facilitate data reuse & ability to “drill across” General lack of satisfaction with all Pharma IT systems PharmaManufacturing Benchmarking Study Data (2005) Future requirements Development of consistent annotation standards to make bioprocess data meaningful Metadata should enable drilling down and across datasets, filter and sift & batch genealogy creation Free text will not be appropriate for all fields Reporting software formats data to ease transfer into analysis software What should SCADA do? Recipe driven batch execution Recipe transfer between units Secure acquisition & storage of Bioreactor data Offline data storage Easy integration of new sensors through OPC Real time Process view What should Bioreactor Controller do? Metadata & Annotations entry Blank Tags for analyser values via OPC Generic PID controller with OPC Input and configurable outputs SCADA Level reporting 60-70% of analysis time is reformatting data for importing into analysis tool Most users have simple reporting requirements Process map of the data flow Search, Sift, Filter

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

最新文档

评论

0/150

提交评论